Casting a wary eye towards the future

Casting a wary eye towards the future

'Mr Sandwich' warns of long-term economic reverberations from the pandemic.

Mr Sirivat has seen his share of economic catastrophe. But he says the current pandemic could have dire consequences.
Mr Sirivat has seen his share of economic catastrophe. But he says the current pandemic could have dire consequences.

Having outlived two economic crises that produced disastrous outcomes for the global economy, stockbroker turned food and drink entrepreneur Sirivat Voravetvuthikun has a warning: the coronavirus pandemic could be the worst economic crisis of his lifetime, posing an explicit danger to Thailand's economic well-being.

After graduating from the University of Texas at Austin in 1974, Mr Sirivat went on to become chief executive of Asia Securities at 28. His success in the early 1990s was shattered by the 1994 stock market crash in Thailand, with the Asian financial crisis in 1997 the final blow to his investment business, particularly a high-end resort condo project at Khao Yai National Park.

Declaring bankruptcy in 2003 with unpaid debt of nearly 1 billion baht, Mr Sirivat persevered and emerged from bankruptcy three years later by slowly building up his business, Sirivat Sandwich, followed by running a chain of coffee shops and a catering operation.

Please log in here to fully view this exclusive content. If you aren't a member yet, simply sign up here. It's totally free & takes only a minute.


Do you like the content of this article?
COMMENT (6)

DR Congo reports fresh Ebola outbreak

KINSHASA - DR Congo reported a fresh Ebola outbreak in its northwest on Monday, the latest health emergency for a country already fighting an epidemic of the deadly fever in the east as well as a surging number of coronavirus infections.

21:45

Japan skies lit up to brighten mood

Simultaneous fireworks displays coloured the night skies in Tokyo and other parts of Japan on Monday, with fireworks makers hoping the sight would cheer up the nation as it struggles with the coronavirus pandemic.

21:29

Gilead: Remdesivir helped moderate patients improve

Gilead Sciences Inc said on Monday its antiviral drug remdesivir showed improvement in patients with moderate Covid-19 in a late-stage study.

21:15